Cannabis leaves with Stock Talk and Cannabis Report labels
(Source: File)

One of Canada’s best known cannabis and consumer packaged goods companies posted significant improvements in free cash flow, gross profitability and adjusted EBITDA in Q1 fiscal 2025, though the business continues to hemorrhage cash. Revenue declined 13 per cent to C$66 million because of divested businesses.

Click here for the full story.

A Canopy Growth distribution centre in Ontario.
(Source: Canopy Growth)

Weekly Update – Top Cannabis News Stories

1 | Top Story: Tilray to acquire four craft beer breweries from Molson Coors

2 | Lifeist’s Chairman explains decision to divest CannMart

3 | Solei launches new THC-infused sparkling beverages and topicals

Top Cannabis Stocks Aug. 9 to Aug. 15, 2024

1. T.TLRY | 6,656 views | .Tilray Brands Inc.
2. T.WEED | 5,174 views | Canopy Growth Corp
3. C.CURA | 4,564 views | Curaleaf Holdings Inc.
4. C.OILS | 3,874 views | Nextleaf Solutions Ltd.
5. T.LABS | 3,436 views | Medipharm Labs Corp.
6. TSX:DN | 1,721 views | Delta 9 Cannabis Inc.


The material provided in this article is for information only and should not be treated as investment advice. For full disclaimer information, please click here.

(Top photo: File)


More From The Market Online

@ the Bell: Stocks rebound into the weekend

The TSX added 0.53% on Friday, ending the week with a 2.17% loss, as investors rekindled risk-on sentiment thanks to a lower oil price.
Oracle jumped 7% on AI cloud demand, lifting the TSX, Dow and Nasdaq, while OpenAI and Anthropic flagged AI risks ahead.

Market Open: Oracle Soars 7% as Markets Rally Despite Oil Above $98 | Sep 11th

Oracle jumped 7% on AI cloud demand, lifting the TSX, Dow and Nasdaq, while OpenAI and Anthropic flagged AI risks ahead.

Promising copper play cleared for solo listing

Copper explorer Blade Resources receives a green light to list its shares on the Canadian Securities Exchange on Monday, September 14th.

StockTalk | Cannabis Report: M&A sparks, insider buys and revenue highs

Curaleaf (TSX:CURA) continues to tout the value it would bring to Aurora Cannabis shareholders, should they agree to an acquisition.